Association between COVID-19 morbidity and mortality rates and BCG vaccination policies in OECD countries.
Bacillus Calmette-Guerin vaccine
COVID-19
OECD
coronavirus infections
epidemiology
Journal
Journal of infection prevention
ISSN: 1757-1774
Titre abrégé: J Infect Prev
Pays: England
ID NLM: 101469725
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
30
05
2020
accepted:
26
10
2020
entrez:
16
4
2021
pubmed:
17
4
2021
medline:
17
4
2021
Statut:
ppublish
Résumé
We compared whether the national BCG vaccination (BCGV) policy influenced coronavirus disease 2019 (COVID-19) in Organisation for Economic Co-operation and Development (OECD) countries. Those currently implementing BCGV have a reduced number of COVID-19 morbidity and mortality cases, compared to those who have never implemented a BCGV policy, suggesting the potential protective effect of BCGV against COVID-19.
Identifiants
pubmed: 33859726
doi: 10.1177/1757177420976812
pii: 10.1177_1757177420976812
pmc: PMC8014005
doi:
Types de publication
Journal Article
Langues
eng
Pagination
91-93Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Tanimoto reports personal fees from MNES Inc., and Medical Network Systems outside of the submitted work. All the other authors declare that they have no competing interests.
Références
Trans R Soc Trop Med Hyg. 2015 Jan;109(1):9-15
pubmed: 25573105
PLoS One. 2015 Jan 30;10(1):e0116380
pubmed: 25635911
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233